Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02783599
Title A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

sarcoma

Therapies

Doxorubicin + Olaratumab

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP


No variant requirements are available.